HomeTARA • NASDAQ
Protara Therapeutics Inc
add
$2.98
2.61%
After Hours:(0.00%)0.00
$2.98
Closed: Jun 18, 4:02:00 PM UTC-4 · USD · NASDAQ · Disclaimer
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 14.12M | 19.18% |
Net income | -11.91M | -7.38% |
Net profit margin | — | — |
Earnings per share | -0.29 | 70.10% |
EBITDA | -14.04M | -19.32% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 124.36M | 125.20% |
Total assets | 168.56M | 147.39% |
Total liabilities | 10.08M | 3.57% |
Total equity | 158.48M | — |
Shares outstanding | 38.58M | — |
Price to book | 0.74 | — |
Return on assets | -20.18% | — |
Return on capital | -21.12% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -11.91M | -7.38% |
Cash from operations | -14.71M | -41.76% |
Cash from investing | -58.35M | -352.61% |
Cash from financing | 1.73M | 2,376.32% |
Net change in cash | -71.34M | -664.15% |
Free cash flow | -12.25M | -93.60% |
Previous close
$3.06
Day range
$2.98 - $3.14
Year range
$1.60 - $10.48
Market cap
114.97M USD
Avg Volume
271.26K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2006
Website
Employees
31
